zonisamide has been researched along with Atherosclerotic Parkinsonism in 2 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tohge, R | 1 |
| Kaneko, S | 1 |
| Morise, S | 1 |
| Oki, M | 1 |
| Takenouchi, N | 1 |
| Murakami, A | 1 |
| Nakamura, M | 1 |
| Kusaka, H | 1 |
| Yakushiji, Y | 1 |
| Ueda, Y | 1 |
| Tokashiki, S | 1 |
| Kanemaru, A | 1 |
| Kojima, T | 1 |
2 other studies available for zonisamide and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's disease.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; GABAergic N | 2021 |
Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease.
Topics: Animals; Anticonvulsants; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Drug Therap | 2012 |